(Credit-Getty Images)
One of the greatest skills anyone can master is the ability to communicate. While most of us do it without thinking, people like politicians, actors and other public speakers need to have a projecting and emoting voice, so that their message gets across to the masses. And having a condition that can affect your ability to speak can make things difficult, and this is something Robert F. Kennedy Jr is very familiar with.
The lead nominee for the US Department of Health and Human Services discussed how a condition has robbed him of his strong speaking voice. He had talked about this condition before as well, where he explained how a disorder called spasmodic dysphonia affected him, a disease that made his voice tremble. This happened when he made a lot of his living by public speaking, often speaking in big halls without any voice amplifications. This not only made it difficult for him to speak, but it also made it difficult for people to understand him!
During his confirmation hearing as President Donald Trump’s nominee to lead the U.S. Department of Health and Human Services, Robert F. Kennedy Jr.'s distinctive, gruff voice was impossible to ignore. At times, his speech patterns made him difficult to understand, bringing renewed attention to the cause of his vocal condition.
Kennedy’s voice is not the result of an infection or respiratory issue. Instead, he has spasmodic dysphonia, a rare neurological disorder that causes involuntary spasms in the muscles controlling the vocal cords. These spasms create a strained or strangled quality to speech, making it challenging to communicate clearly.
Spasmodic dysphonia is a form of dystonia, a neurological condition affecting muscle control. It is estimated to impact up to 50,000 people in North America. The disorder originates in the basal ganglia, the part of the brain that regulates muscle contractions. When signals are disrupted, affected muscles move involuntarily or freeze in abnormal positions.
Other forms of dystonia can affect various body parts, including the neck which is called cervical dystonia, eyes which is called blepharospasm, or limbs. Some types of vocal dystonia, like lingual protrusion dystonia, can cause the tongue to protrude when speaking, further distorting speech.
Dystonia remains relatively unknown, yet an estimated 250,000 Americans have some form of the condition according to American Association of Neurological Surgeons. It ranks as the third most common movement disorder, following essential tremor and Parkinson’s disease. There is no cure, and treatment options are limited. Some medications can help by altering brain activity, though they are often a first-line attempt rather than a definitive solution.
Physical and speech therapy are commonly used, and acupuncture or other alternative treatments may provide relief. For severe cases, deep-brain stimulation is a last-resort option. Botulinum toxin which is more commonly known as Botox, injections are a widely used treatment for certain types of dystonia, including blepharospasm. These injections relax affected muscles, reducing spasms but not addressing the underlying neurological issue.
Experts explain how although you cannot treat the disorder but rather the phenomena. According to WebMD the medications help you ease the vocal folds like the Myofascial release, which stretches your muscles and eases symptoms, anti-anxiety medication to ease the stress so that the symptoms do not get worse etc. For reasons still not understood, dystonia often affects the body part most essential to a person’s profession.
WebMD tells us that there is no way to prevent Spasmodic Dysphonia, while there is usually some lifestyle changes and habits you can change if you want to prevent this issue, but no such risk factor has been associated with Spasmodic Dysphonia. Beyond the physical challenges, spasmodic dysphonia can take a profound toll on a person’s emotional well-being and career. According to Dysphonia International, many individuals feel their voice no longer reflects their personality, emotions, or competence.
The condition can lead to emotional distress, job loss, forced career changes, reduced social interactions, and strained personal relationships. As Kennedy himself acknowledged, the condition makes communication more difficult, impacting both public perception and personal confidence.
Credits: Canva
Novovax, the maker of the only protein-based COVID-19 vaccine available in the US announced that its shot is on track for full approval from the US Food and Drug Administration (FDA). It is an important development for the company. It has sent its stock soaring up to 21% on Wednesday morning for trading. It is said that this will also ease the fears of political interference that may have caused delay in the process.
While the other mRNA vaccines from Pfizer and Moderna have received full FDA approval for specific age groups, Novovax's vaccine still awaits the approval. It is only authorized for emergency use.
The emergency use authorization or the EUA allows vaccines to be distributed during public health emergencies. However, once the emergency ends, the FDA can remove them from the market unless full approval is granted.
The FDA originally planned to approve Novovax's vaccine by April 1. However, as per the inside sources, the process was paused at the direction of Dr Sara Brenner, the FDA's acting commissioner. The delay has also raised concerns, especially after Dr Peter Marks, the FDA's longtime vaccine chief, reportedly left his post due to disagreements with the Health Secretary Robert F Kennedy Jr, who is a known vaccine skeptic.
In the past, RFK Jr. has worked closely with many anti-vaccine activists who work for his nonprofit group Children's Health Defense. While in his recent speech, he said that he has "never been anti-vax and have never told the public to avoid vaccination", his track record shows otherwise.
In a podcast interview, he said, "There is no vaccine that is safe and effective" and told FOX News that he still believes in the now long-debunked idea that vaccines can cause autism. In another 2021 podcast, he urged people to "resist" CDC guidelines on getting their kids vaccinated. "I see somebody on a hiking trail carrying a little baby and I say to him, better not get them vaccinated," he said.
His non-profit also led an anti-vax campaign sticker and he appeared next on the screen to a sticker that read: "If you are not an anti-vaxxer you are not paying attention," reports AP.
The FDA recently asked Novavax to outline a plan to collect additional clinical data from people who have received the vaccine. Novavax says it is “engaging with the FDA expeditiously” and hopes to secure full approval as soon as possible. Full FDA approval is considered the gold standard, as it reflects a higher level of scrutiny and confidence in a product’s safety and effectiveness.
The COVID-19 vaccines that are currently available in the US teach the immune system to recognize the virus' spike protein, which is its outer coating. the Pfizer and Moderna's mRNA vaccine deliver genetic instructions that help the body create a temporary version of spike protein that trigger an immune response. In contrast, the Novovax's shot contains lab-grown copies of the spike protein itself, which are then combined with a substance that boosts the immune response.
This traditional approach—called a protein-based vaccine—has been used for decades in vaccines for diseases like hepatitis B and shingles. For people who are hesitant about mRNA vaccines, Novavax offers an alternative that uses a well-established method.
Credits: Canva
The US Food and Drug Administration (FDA) has granted approval to Dupixent or dupilumab for the treatment of chronic spontaneous urticaria (CSU) in adults and adolescents who are aged 12 years or are older. The approval caters to those who would have to continue to experience symptoms despite being on histmamine-1 (H1) antihistamine therapy. These are medications that block the effects of histamine on H1 receptors and are primarily used to treat allergies or allergic reactions.
It is a biologic medication which targets specific pathways in the immune system. It is a monoclonal antibody, which is designed to inhibit the signaling of two key proteins, namely: interleukin-4 (IL-4) and interleukin-13 (IL-13). These two play a central role in type 2 inflammation, which is believed to contribute to a variety of allergic and inflammatory conditions. It is also approved for other conditions like atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis.
As per the 2017 study published in Canadian Medical Association Journal, titled Chronic spontaneous urticaria, the condition is defined by the presence of hives daily or almost for at lease six weeks. The study also mentions that the condition mostly affects the working population and may have a substantial impact on quality of life.
As per the American College of Allergy, Asthma & Immunology, it affects about 20% of people at some time during their lives. It can also be triggered by many substances or situations and usually starts as an itchy patch of skin that turns into swollen red welts.
Rarely, cases of hives last more than six weeks and could end up staying for up to 5 years. This condition is known as chronic spontaneous urticaria or idiopathic urticaria. It can affect 1.4% of the general population and is seen in women twice as commonly as men.
For many individuals, the condition is both physically uncomfortable and emotionally distressing, often interfering with sleep, daily activities, and overall quality of life. In some patients, standard antihistamines fail to control the symptoms, leaving them in need of more effective treatment options.
The FDA has based its decision on the results of two phase 3 clinical trials that studied the drug ass an add-on to the standard antihistamine therapy. The trials also included patients who had not previously been treated with biologic therapies and who continued to show symptoms despite being on antihistamines.
In both studies, Dupixent met its primary and key secondary endpoints. Patients receiving the medication showed a significant reduction in the severity of itching and urticaria activity after 24 weeks, compared to those who received placebo plus antihistamines. Additionally, those on Dupixent were more likely to achieve well-controlled disease or a complete response by the end of the study period. The safety profile observed in these trials was consistent with what has already been documented in other approved uses of Dupixent.
The approval of Dupixent for CSU represents a significant advancement for patients and healthcare providers. It offers new hope for those who have been living with poorly controlled symptoms, enhancing their ability to manage the condition more effectively and improve overall quality of life.
A future where heart attacks, strokes, and even cancer might be predictable is coming near—not only cured—thanks to a small, new eco-friendly sensor that can detect harmful levels of cholesterol in real-time. Scientists in India have created a revolutionizing optical sensor that can immediately identify high cholesterol, which could change the way we check for heart disease around the world.
At the core of this innovation is a unique biosensing platform that's not just extremely sensitive and affordable but also eco-friendly. Created by scientists at the Institute of Advanced Study in Science and Technology (IASST), Guwahati, in India this next-generation optical sensing tool is constructed using silk fiber functionalized with phosphorene quantum dots. Their work, reported in the highly regarded Nanoscale journal by the Royal Society of Chemistry, breaks new ground for non-invasive, real-time disease monitoring.
Elevated cholesterol levels, particularly high LDL (low-density lipoprotein) or "bad" cholesterol, are frequently associated with silent but lethal diseases such as atherosclerosis, myocardial infarction, hypertension, venous thrombosis, and even some cancers. But the greatest concern? Most individuals never realize they're at risk until it's too late.
Cholesterol serves a double function in human physiology. It is required for the manufacture of vitamin D, bile acids, and steroid hormones and for the preservation of blood and nerve cell integrity. But too much—especially increased LDL (low-density lipoprotein, or "bad") and decreased HDL (high-density lipoprotein, or "good") cholesterol—can cause arteries to become clogged with plaque, blocking the flow of blood and causing life-threatening events.
That's why it is essential to detect these issues early on. And this new optical sensor might prove a breakthrough in the global battle against chronic illnesses by detecting risk signs before symptoms develop.
What makes this device a scientific milestone is the integration of materials and techniques that are innovative and environmentally friendly. The scientists employed silk fiber as the substrate and functionalized it with phosphorene quantum dots, which are renowned for their superior electrical and optical properties.
The sensor was also incorporated into a cellulose nitrate membrane to create an electrical sensing platform that can detect trace amounts of cholesterol—even below the normal detection limit. That's correct: this device can detect cholesterol changes before they reach clinical levels, making it perfect for regular health monitoring and preventive medicine.
This device produces no electronic waste, providing a green alternative to traditional diagnostic technologies.
In contrast to most experimental laboratory creations that fail to translate to real-world use, this device is highly compatible with real biological samples. It was able to detect cholesterol levels in human blood serum, rat blood, and even milk—showing its strength and versatility across mediums.
Such reliability makes it extremely versatile for application in point-of-care (POC) environments, possibly in clinics, pharmacies, or even at home. That translates to no more complicated lab tests or weeks of waiting for results.
One of the main causes of abnormal cholesterol is familial hypercholesterolemia, a genetic condition in which the liver has difficulty breaking down cholesterol. This makes regular checks even more crucial, particularly for those with a family history of heart disease, says the British Heart Foundation.
Obesity, inflammation, smoking, alcohol consumption, and sedentary lifestyles all increase LDL levels while simultaneously reducing protective HDL cholesterol. In many cases, the symptoms remain invisible—making it a ticking time bomb inside the body.
Visible signs such as deposits of fat beneath the skin (xanthomas), yellowish spots on or near the eyelids (xanthelasmas), or white circles around the iris (corneal arcus) may appear in rare cases. But for many individuals, high cholesterol has no warning signals.
Though statins, drugs that inhibit the liver production of cholesterol—are common and have been shown to be effective, they're not the only solution. Lifestyle modification continues to be the cornerstone. Physicians suggest:
Physical activity on a daily basis: A minimum of 30 minutes to increase HDL and decrease LDL.
Changes in diet: Increased fiber, reduced saturated fats, and decreased processed foods.
Smoking and alcohol avoidance: Both are bad habits that make LDL worse and are detrimental to heart health.
The objective isn't merely treatment but prevention, and that is where early diagnosis using devices like this optical sensor comes into play.
This emerging optical sensor, capable of detecting cholesterol, is more than an academic achievement—it's a sea change. It signals a new world where your health is cared for proactively, sustainably, and customarily. Beyond its current ability to be handheld, this equipment may be designed into wearable devices, home health test kits, or even phones that are smarter with health attachments.
© 2024 Bennett, Coleman & Company Limited